 |
| Scratching the surface: Researchers reveal insights on silicon semiconductors |
30 September 2006 - Virginia Polytechnic Institute and State University
'Smaller. Faster. Wildly complex.' This could easily be the motto for semiconductors-the materials that, among lots of other advances in electronics, allow cell phones to continuously shrink in size while increasing the number of their mind-boggling functions. |
|
|
| Scientists find gene in obese mice that increases Type 2 diabetes |
30 September 2006 - University of Wisconsin-Madison
In a painstaking set of experiments in overweight mice, scientists from the University of Wisconsin-Madison have discovered a gene that appears to play an important role in the onset of type 2 diabetes. |
|
|
| Sheffield secures BOC chemical engineer hat-trick honour |
30 September 2006 - BOC Gases
A North Wales student has helped the University of Sheffield complete a hat-trick of wins of the BOC Award for the Best Chemical Engineering Student at a gala awards evening in London. |
|
|
| Good designs brewing at Access Business Group |
30 September 2006 - Boothroyd Dewhurst
Access Business Group (Ada, Michigan) develops, manufactures, and distributes a comprehensive range of durable goods, including patented water treatment and air filtration systems, and an award-winning coffee maker. Access has emerged as a leader in water filtration products, using special carbon and ultraviolet light technology for optimal health and taste benefits. |
|
|
| Design-For-Manufacturing-and-Assembly analysis can help take cost & complexity out of your products |
30 September 2006 - Boothroyd Dewhurst
If you want to take cost and complexity out of your products, a design-for-manufacturing-and-assembly analysis can help. But at what point in the product development cycle should you apply that analysis? |
|
|
| New approach to product design that promised |
30 September 2006 - Boothroyd Dewhurst
Remember Japan? In the fall of 1989, both Business Week and Industry Week broke stories about a new approach to product design that promised to make U.S. manufacturing more competitive with our upstart neighbor to the east. |
|
|
| BTG licenses Barnes & Noble to its online navigation tracking patents |
30 September 2006 - BTG
BTG announces it has reached a settlement with BarnesandNoble.com over a patent infringement lawsuit filed by BTG. The financial terms of the settlement with Barnes & Noble are undisclosed. As a result of this settlement, BTG has dismissed its claims and granted Barnes & Noble a non-exclusive license to patents covering technology for tracking the navigational path of a user through the World Wide Web. |
|
|
| BTG licenses the Electro-Absorption Modulator & Distributed FeedBack Laser Technologies to Mitsubishi Electric |
30 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, today announced that it has signed a licence agreement with Mitsubishi Electric Corporation for the Electro-Absorption Modulator and the Distributed Feedback laser technologies. Both of these technologies, used to produce high quality modulated optical signals at data rates of 1.0 Gbit/s and above, play an integral role in making more efficient use of long distance optical telecommunications networks. |
|
|
| X-ray crystallography structure of human cytochrome 2C9 shows good agreement with Lewis P450 Model |
30 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, today highlighted the reference in April’s edition of Pharmacogenomics of the remarkable three-dimensional alignment of the structure of the human cytochrome P450, CYP2C9, depicted in Professor Lewis’ 3-D Model, compared to the X-ray crystal structure solved by P.A. Williams et al. The Lewis P450 Models, including those of CYP2C9, are being commercialised exclusively by BTG. |
|
|
| BTG announces licensing agreement with Gambro Renal |
30 September 2006 - BTG
BTG, the global technology commercialisation company, announced today that it has successfully licensed patents surrounding a hemofiltration device developed at Cincinnati Children’s Hospital Medical Center to international dialysis product manufacturer Gambro Renal Products. The agreement involved a down payment and provides for ongoing royalties. BTG acquired the rights to commercialise this intellectual property from Cincinnati Children’s Hospital. |
|
|
| BTG licenses Barnes & Noble to its online navigation tracking patents |
30 September 2006 - BTG
BTG announces it has reached a settlement with BarnesandNoble.com over a patent infringement lawsuit filed by BTG. The financial terms of the settlement with Barnes & Noble are undisclosed. As a result of this settlement, BTG has dismissed its claims and granted Barnes & Noble a non-exclusive license to patents covering technology for tracking the navigational path of a user through the World Wide Web. |
|
|
| More fertile cattle worth millions to producers |
30 September 2006 - CSIRO
Research into finding the links between the genetic make-up of bulls and the fertility of their female progeny could be worth millions of dollars to Australian beef producers. |
|
|
| Welfare reform fails to end poverty, study says |
30 September 2006 - University of Chicago
Welfare reform in Wisconsin has dramatically cut public assistance roles, but efforts in Milwaukee to place welfare recipients into jobs have not succeeded in pulling people out of chronic poverty and into self-sufficiency, according to a study by the Universities of Chicago and Wisconsin being released Tuesday. |
|
|
| Study: 'BAY drug' helps kidney cancer patients |
29 September 2006 - University of Chicago
Each year, about 36,000 people in the United states will be told they have kidney cancer. One-third of them will die. Researchers are now taking a look at a new treatment for patients in whom kidney cancer has spread. |
|
|
| International presentation on sheep worm research |
29 September 2006 - CSIRO
Work by CSIRO Livestock Industries researcher, Kerri Tyrrell, which validates a new method of controlling a major parasite in Australian sheep, is being presented to the International Controlled Release Society conference in Vienna this week. |
|
|
| The Midas Bug, the bacterial alchemy of gold |
29 September 2006 - CSIRO
Bacteria play an important role in the formation of gold nuggets in Australia according to new research published this month in the international journal, Science today. |
|
|
| Parkes finds unexpected heartbeat’ in star |
29 September 2006 - CSIRO
Astronomers using CSIRO's Parkes telescope in eastern Australia have detected radio “heartbeats” from a star that was not expected to have them. A US-Australian research team found that a “magnetar” a kind of star with the strongest magnetic fields known in the Universe, is giving off extraordinary radio pulses, which links this rare type of star with the much more common “radio pulsars”. |
|
|
| BTG strengthens non-invasive prenatal diagnostic technology patent portfolio |
29 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced today that it has strengthened its non-invasive prenatal diagnosis patent portfolio through the acquisition of a novel cellular foetal DNA diagnostic. The technology, developed by Professor Maj Hulten, has the ability to identify foetal DNA from the mixed cell population in the maternal bloodstream. This will allow foetal chromosomes to be investigated for several chromosome disorders, including Trisomy 21 (underlying cause of Downs syndrome) from a maternal blood sample, without contamination by maternal chromosomes. |
|
|
| Collaboration with Irish BioVentures to assist BTG in finding, developing and commercialising technologies in Ireland |
29 September 2006 - BTG
BTG, the global technology commercialisation company, today announced a strategic alliance with Irish BioVentures International Ltd, Ireland’s premier source of venture development services for the life sciences and healthcare industries. IBV will work with BTG to source and review Intellectual Property assets and venture opportunities within the life sciences. This agreement enables BTG to expand its sourcing activities in both the Republic of Ireland and Northern Ireland. |
|
|
| Parkes finds unexpected heartbeat’ in star |
29 September 2006 - CSIRO
Astronomers using CSIRO's Parkes telescope in eastern Australia have detected radio “heartbeats” from a star that was not expected to have them. A US-Australian research team found that a “magnetar”, a kind of star with the strongest magnetic fields known in the Universe, is giving off extraordinary radio pulses, which links this rare type of star with the much more common “radio pulsars”. |
|
|
| International presentation on sheep worm research |
29 September 2006 - CSIRO
Work by CSIRO Livestock Industries researcher, Kerri Tyrrell, which validates a new method of controlling a major parasite in Australian sheep, is being presented to the International Controlled Release Society conference in Vienna this week. Ms Tyrrell successfully combined two chemicals in a unique way to produce a single controlled-release formulation for effective long-term protection against the damaging intestinal worm, Haemonchus contortus. |
|
|
| The Midas Bug - the bacterial alchemy of gold |
29 September 2006 - CSIRO
according to new research published this month in the international journal, Science today. The paper highlights the findings of a Cooperative Research Centre for Landscape Environments and Mineral Exploration project by CSIRO researcher, Dr Frank Reith. |
|
|
| Innovative pharmacological approach for the treatment of sleep-related breathing disorders |
29 September 2006 - BTG
BTG, the medical innovations company, announced today that it has initiated patient enrolment for a proof of mechanism clinical trial for BGC20-0166, its novel pharmacologic therapy for the treatment of obstructive sleep apnoea. BGC20-0166 targets two distinct mechanisms of serotonin signaling. As the lead programme in BTG's drug repositioning portfolio, which currently consists of five development programmes involving new therapeutic uses or enhanced formulation of approved drugs, BTG has advanced BGC20-0166 from preclinical validation studies to the current clinical trial in less than eighteen months. The goals of the current clinical study are to investigate the efficacy of BGC20-0166 and to establish mechanistic proof of concept. |
|
|
| KetoCytonyx reports positive Phase I study of neuroprotectant |
29 September 2006 - BTG
Ketocytonyx, Inc., a pharmaceutical development company focused on cell protection therapeutics, today announced the successful completion of a Phase I clinical study of KTX 0101, its lead therapeutic targeting prevention of cognitive impairment in patients undergoing coronary artery bypass graft surgery. |
|
|
| Collaboration with Irish BioVentures to assist BTG in finding, developing and commercialising technologies |
29 September 2006 - BTG
BTG, the global technology commercialisation company, today announced a strategic alliance with Irish BioVentures International Ltd, Ireland’s premier source of venture development services for the life sciences and healthcare industries. |
|
|
| BTG strengthens non-invasive prenatal diagnostic technology patent portfolio |
29 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced today that it has strengthened its non-invasive prenatal diagnosis patent portfolio through the acquisition of a novel cellular foetal DNA diagnostic. |
|
|
| KetoCytonyx reports positive Phase I study of neuroprotectant |
29 September 2006 - BTG
Ketocytonyx, Inc., a pharmaceutical development company focused on cell protection therapeutics, today announced the successful completion of a Phase I clinical study of KTX 0101, its lead therapeutic targeting prevention of cognitive impairment in patients undergoing coronary artery bypass graft surgery. |
|
|
| Innovative pharmacological approach for the treatment of sleep-related breathing disorders |
29 September 2006 - BTG
BTG, the medical innovations company, announced today that it has initiated patient enrolment for a proof of mechanism clinical trial for BGC20-0166, its novel pharmacologic therapy for the treatment of obstructive sleep apnoea. BGC20-0166 targets two distinct mechanisms of serotonin signaling. |
|
|
| Manufacturing in China? The true cost may surprise you |
29 September 2006 - Boothroyd Dewhurst
Examining realistic estimates of the cost of outsourcing puts the magic bullet of Chinese manufacturing into question. Nick Dewhurst of Boothroyd Dewhurst has some eye-opening data on what it may actually cost you to move manufacturing of a product overseas. In the chart above, part costs represent 72% of a product, overhead is 24%, and labor only 4%. |
|
|
| Design for assembly dramatically reduces complexity of plasma arc cutter |
29 September 2006 - Boothroyd Dewhurst
The engineers at Hypertherm Inc., a maker of plasma cutting systems,know a thing or two about cutting metals. They also know how to cut cost. A lot of cost. While redesigning one of the company's best-selling plasma cutting systems, they managed to reduce parts' count from more than 1,000 components to fewer than 500. |
|
|
| DFM concurrent costing 2.0 software from Boothroyd Dewhurst promotes should-cost analysis |
29 September 2006 - Boothroyd Dewhurst
Boothroyd Dewhurst, Inc., developer of the internationally recognized Design for Manufacture and Assembly software, announces a major new release, DFM Concurrent Costing Version 2.0. DFM Concurrent Costing 2.0 enables engineering organizations and their supply chains to take a multidisciplinary approach to cost assessment early in product design. |
|
|
| BOC Edwards and AUECC move forward with China Wet Chemical Production Plan |
29 September 2006 - BOC Gases
Following announcement of its equity position in Asia Union Electronic Chemical Corporation, BOC Edwards announced today that AUECC is moving forward with plans to supply wet process chemicals to the growing electronics manufacturing industry in China, and has formed an equity joint venture with Shanghai Huayi (Group) Company. The new venture is called Shanghai Huayi Microelectronic Material Co. Ltd. |
|
|
| Akrion's Goldfinger Technologies selects BOC Edwards Chemical Blending Systems |
28 September 2006 - BOC Gases
BOC Edwards announced today that it has received an order from Akrion for 19 additional chemical blend and delivery modules to support Goldfinger Mach2HP megasonic wafer cleaning tools at a major Asian fab. |
|
|
| New technologies to reduce production costs |
28 September 2006 - Boothroyd Dewhurst
The day of the dedicated machine is dead. Shops must be lean, flexible, do more with less, and design for manufacturability. To do these, average manufacturers are shifting to lean manufacturing or Six Sigma principles, exploiting the advantages of R&D, putting spot solutions in place, and last, implementing productlifecycle management. |
|
|
| If we maintain U.S. R&D leadership, both government support & industry practices need to be reconsidered |
28 September 2006 - Boothroyd Dewhurst
The experts warn: If maintaining U.S. R&D leadership is the goal, then both government support and industry practices need to be reconsidered. They contend that federal funding of basic research is slipping even as industry turns from basic to applied research. Further, they say industry has tilted too far toward equating R&D success more with product development than with optimizing the innovation process. In this, the first part of a four-part series, Recapturing R&D Leadership, IW explores the scope of the challenges facing U.S. manufacturers. |
|
|
| Lead compound has potential to improve the treatment of migraine |
28 September 2006 - BTG
BTG plc, the medical innovations company, and Asterand plc (formerly Pharmagene plc) announce that the companies have entered into an exclusive licence agreement, whereby BTG acquires the rights to a series of compounds discovered and developed by Asterand to treat painful conditions such as migraine headache. |
|
|
| Short-term administration with novel drug candidate significantly reduces insulin |
28 September 2006 - BTG
A study published in the New England Journal of Medicine demonstrates that in patients with type 1 diabetes, a six day course of therapy with TRX4 (ChAglyCD3) preserves the function of insulin-producing beta cells in the pancreas and reduces the amount of administered insulin needed to control blood glucose levels for at least 18 months. |
|
|
| BTG and DxS sign exclusive licence with AstraZeneca to commercialise ARMS DNA diagnostic technology |
28 September 2006 - BTG
DxS and BTG announced today that they have signed an exclusive licence with AstraZeneca to commercialise the company’s proprietary Amplification Refractory Mutation System DNA diagnostic technology. ARMS is a simple, reliable and widely used method for the detection of gene mutations and single nucleotide polymorphisms. |
|
|
| BTG takes exclusive licence to new class of cancer drug from Cancer Research Technology |
28 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced that it has concluded a licence and research collaboration agreement with Cancer Research Technology Limited, the technology transfer company of the charity Cancer Research UK, and The Institute of Cancer Research, for a new class of cancer drug. |
|
|
| Short-term administration with novel drug candidate significantly reduces insulin need in newly diagnosed Type 1 Diabetics |
28 September 2006 - BTG
A study published in the New England Journal of Medicine demonstrates that in patients with type 1 diabetes, a six day course of therapy with TRX4 (ChAglyCD3) preserves the function of insulin-producing beta cells in the pancreas and reduces the amount of administered insulin needed to control blood glucose levels for at least 18 months. |
|
|
| Lead compound has potential to improve the treatment of migraine |
28 September 2006 - BTG
BTG plc, the medical innovations company, and Asterand plc (formerly Pharmagene plc) announce that the companies have entered into an exclusive licence agreement, whereby BTG acquires the rights to a series of compounds discovered and developed by Asterand to treat painful conditions such as migraine headache. |
|
|
| Australia-UK teams join to fight flu |
28 September 2006 - CSIRO
In a joint application to the British Medical Research Council, Dr Jennifer McKimm-Breschkin of CSIRO Molecular and Health Technologies and Dr Andrew Watts of the University of Bath will share equally in a £408,000 (A$ 1M) grant over three years to tackle pandemic flu. Dr McKimm-Breschkin is an expert in testing inhibitors of flu and evaluating drug resistance. Dr Watts brings his medicinal chemistry expertise to the collaboration and will work on the design of new drug molecules. |
|
|
| Research partnership to protect the Coorong |
28 September 2006 - CSIRO
One of Australia’s most significant wetlands, the Coorong, at the mouth of the River Murray, is the focus of a new multi–million dollar research partnership that aims to improve the ecological health of the region and protect threatened birds and fish. |
|
|
| BTG takes licence to new class of cancer drug from Cancer Research Technology and The Institute of Cancer Research |
28 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced that it has concluded a licence and research collaboration agreement with Cancer Research Technology Limited, the technology transfer company of the charity Cancer Research UK, and The Institute of Cancer Research, for a new class of cancer drug. |
|
|
| BTG and DxS sign exclusive licence with AstraZeneca to commercialise ARMS DNA diagnostic technology |
28 September 2006 - BTG
DxS and BTG announced today that they have signed an exclusive licence with AstraZeneca to commercialise the company’s proprietary Amplification Refractory Mutation System DNA diagnostic technology. ARMS is a simple, reliable and widely used method for the detection of gene mutations and single nucleotide polymorphisms. |
|
|
| Research partnership to protect the Coorong |
28 September 2006 - CSIRO
One of Australia’s most significant wetlands, the Coorong, at the mouth of the River Murray, is the focus of a new multi–million dollar research partnership that aims to improve the ecological health of the region and protect threatened birds and fish. |
|
|
| Australia-UK teams join to fight flu |
28 September 2006 - CSIRO
In a joint application to the British Medical Research Council, Dr Jennifer McKimm-Breschkin of CSIRO Molecular and Health Technologies and Dr Andrew Watts of the University of Bath will share equally in a £408,000 (A$ 1M) grant over three years to tackle pandemic flu. Dr McKimm-Breschkin is an expert in testing inhibitors of flu and evaluating drug resistance. Dr Watts brings his medicinal chemistry expertise to the collaboration and will work on the design of new drug molecules. |
|
|
| Plastic meltdown technology a real lifesaver |
27 September 2006 - CSIRO
A polymer that transforms into a fireproof ceramic in a blaze is set to have a major impact on the $12 billion global passive fire-protection market, and stands to save many lives. |
|
|
| A three-way coal research and development Joint Statement was signed |
27 September 2006 - CSIRO
The three signatories were the Japan Coal Energy Centre; Australian Coal Research Ltd, a company established by the Australian coal industry to manage the activities of the Australian Coal Association Research Program; and the Commonwealth Scientific and Industrial Research Organisation. |
|
|
| Announcement highlights corporate trend towards IP asset licensing |
27 September 2006 - BTG
BTG, a global technology commercialisation company, and Corning Incorporated, a diversified technology company, announced today that they have signed a representation agreement whereby BTG will seek licensees on behalf of Corning for a portfolio of Corning patents related to a widely-used glass moulding process. |
|
|
| A three-way coal research and development Joint Statement was signed |
27 September 2006 - CSIRO
The three signatories were the Japan Coal Energy Centre; Australian Coal Research Ltd, a company established by the Australian coal industry to manage the activities of the Australian Coal Association Research Program; and the Commonwealth Scientific and Industrial Research Organisation. |
|
|
| Plastic meltdown technology a real lifesaver |
27 September 2006 - CSIRO
A polymer that transforms into a fireproof ceramic in a blaze is set to have a major impact on the $12 billion global passive fire-protection market, and stands to save many lives. Fire accidents cause over 70,000 deaths and $115 billion worth of property damage a year worldwide. The ceramifying polymers have been developed by CSIRO and the CRC for Polymers, and are being commercialised by CRC spin-off company Ceram Polymerik. |
|
|
| BTG to commence US phase II clinical safety study of Varisolve |
27 September 2006 - BTG
BTG plc, the medical innovations company, today announces that it intends to complete preparations for and commence a US phase II clinical safety study of Varisolve, the novel injectable microfoam treatment for varicose veins. |
|
|
| BTG plc: Publication of positive data from TRX4 type 1 diabetes study |
27 September 2006 - BTG
BTG plc, the medical innovations company, notes that TolerRx, Inc., BTG’s licensee for the anti-CD3 technology, has announced publication of positive Phase II data on TRX4 (ChAglyCD3), showing that a six-day course of TRX4 therapy in patients with type 1 diabetes reduced the amount of insulin needed to control blood glucose levels for at least 18 months. |
|
|
| KetoCytonyx commences Phase I Study for Neuroprotectant KTX 0101 |
27 September 2006 - BTG
KetoCytonyx, Inc, a pharmaceutical development company focused on cell protection therapeutics, today announced that a Phase I clinical study has begun on KTX 0101, its lead therapeutic with a target indication of prevention of cognitive impairment in patients undergoing Coronary Artery Bypass Graft surgery. |
|
|
| KetoCytonyx commences Phase I Study for Neuroprotectant KTX 0101 |
27 September 2006 - BTG
KetoCytonyx, Inc, a pharmaceutical development company focused on cell protection therapeutics, today announced that a Phase I clinical study has begun on KTX 0101, its lead therapeutic with a target indication of prevention of cognitive impairment in patients undergoing Coronary Artery Bypass Graft surgery. |
|
|
| Announcement highlights corporate trend towards IP asset licensing |
27 September 2006 - BTG
BTG, a global technology commercialisation company, and Corning Incorporated, a diversified technology company, announced today that they have signed a representation agreement whereby BTG will seek licensees on behalf of Corning for a portfolio of Corning patents related to a widely-used glass moulding process. |
|
|
| BTG plc: Publication of positive data from TRX4 type 1 diabetes study |
27 September 2006 - BTG
BTG plc, the medical innovations company, notes that TolerRx, Inc., BTG’s licensee for the anti-CD3 technology, has announced publication of positive Phase II data on TRX4 (ChAglyCD3), showing that a six-day course of TRX4 therapy in patients with type 1 diabetes reduced the amount of insulin needed to control blood glucose levels for at least 18 months. |
|
|
| BTG to commence US phase II clinical safety study of Varisolve |
27 September 2006 - BTG
BTG plc, the medical innovations company, today announces that it intends to complete preparations for and commence a US phase II clinical safety study of Varisolve, the novel injectable microfoam treatment for varicose veins. |
|
|
| Evaluation of instrument panel designs for cost of manufacture and environmental impact |
27 September 2006 - Boothroyd Dewhurst
This paper considers possibilities for redesign of a current model Truck Instrument Panel in order to reduce manufacturing costs and to increase the likelihood of end-of-life material recovery. A new design concept for the Instrument Panel is proposed which would have had the potential to achieve the following benefits: |
|
|
| A less-costly fuel-cell design |
27 September 2006 - Boothroyd Dewhurst
To get around the problem of a nonexistent hydrogen infrastructure, a research firm examined reformer systems for fuel cells that produce hydrogen from gasoline. Directed Technologies Inc., Arlington, Va. (directedtechnologies.com), recently completed a multiyear study funded by the Dept. of Energy. |
|
|
| Successful qualification program indicates F80 good complement to TELFORMULA platform |
27 September 2006 - BOC Gases
BOC Edwards, a global supplier of materials and subsystems for electronics manufacturing, announced today it has successfully completed a two-year fluorine qualification program with Tokyo Electron Limited, Japan, a major manufacturer of semiconductor production equipment. The BOC Edwards' Generation-F80 prototype fluorine generator has supplied up to 80 l/hr to multiple TELFORMULA 300 mm LPCVD tools at TEL/AT's Tohoku, Japan facility. |
|
|
| BOC increases focus on independent distributor channel |
26 September 2006 - BOC Gases
BOC plans to increase its focus on its independent distributor channel and has identified opportunities for improvement following a Distributor Advisory Council meeting in Saratoga, N.Y. |
|
|
| Expanded use of Design for Manufacture & Assembly software will help practices in product cost analysis |
26 September 2006 - Boothroyd Dewhurst
Boothroyd Dewhurst, Inc., developers of Design for Manufacture and Assembly software, today announced that Plug Power Inc., headquartered in Latham, N.Y., has purchased a corporate license for DFMA software. |
|
|
| DFA is used to enhance value engineering/value analysis workshop outcomes |
26 September 2006 - Boothroyd Dewhurst
In the automotive industry, the pressure to reduce prices is present at all levels, from the vehicle manufacturer through to the lowest level of the supply base. Most first and second tier suppliers are faced with contractual performance or productivity clauses which require annual downward price adjustments of 3 to 5% on the products they provide to the OEM. |
|
|
| America’s secret weapon: Better designs |
26 September 2006 - Boothroyd Dewhurst
The trend to shorter product cycles is also creating shorter design cycles, resulting in higher part costs, manufacturing problems, and even warranty issues down the road. Careful up-front work on product design can easily save 50% on total costs, and may even be America’s hidden weapon in winning manufacturing business back from China. |
|
|
| TolerRx, Inc. Advance TRX4 in Type 1 Diabetes, Adds seven new investors including FrontPoint Partners |
26 September 2006 - BTG
TolerRx, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with diseases of the immune system, announced that it has completed a $35.6 million financing, which included funding from the Juvenile Diabetes Research Foundation, the world's largest charitable sponsor of research in Type 1 diabetes. |
|
|
| BTG plc: Varisolve given FDA approval to recommence US clinical trials |
26 September 2006 - BTG
BTG plc, the medical innovations company, today announces that its subsidiary Provensis has received approval from the US Food and Drug Administration to resume clinical development of Varisolve, which is being developed as a novel microfoam treatment for varicose veins. |
|
|
| Innovative pharmacological approach for the treatment of sleep-related disorder |
26 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, today announced that it has signed a licensing and research agreement with the University of Illinois at Chicago to further develop a novel pharmacological therapy for the treatment of sleep apnoea. |
|
|
| BTG licenses new prostate cancer drug to Cougar Biotechnology |
26 September 2006 - BTG
BTG, the global technology commercialisation company and Los Angeles-based Cougar Biotechnology today announced that they have signed a licence agreement in which Cougar is granted worldwide exclusive rights to develop and commercialise abiraterone acetate, a potential novel therapeutic for treatment of advanced prostate cancer. |
|
|
| BTG licenses new prostate cancer drug to Cougar Biotechnology |
26 September 2006 - BTG
BTG, the global technology commercialisation company and Los Angeles-based Cougar Biotechnology today announced that they have signed a licence agreement in which Cougar is granted worldwide exclusive rights to develop and commercialise abiraterone acetate, a potential novel therapeutic for treatment of advanced prostate cancer. BTG will receive an upfront cash payment and will benefit from further development milestones and a royalty on sales. Detailed financial terms were not disclosed. |
|
|
| Innovative pharmacological approach for the treatment of sleep-related disorder |
26 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, today announced that it has signed a licensing and research agreement with the University of Illinois at Chicago to further develop a novel pharmacological therapy for the treatment of sleep apnoea. BTG plans to invest in the development of this innovative therapy to expand its portfolio of therapeutic programmes, particularly in the area of drug repositioning. Under the terms of the agreement, UIC grants BTG specific exclusive rights to intellectual property and inventions related to the development of therapeutic treatment of sleep apnoea, as well as rights to new intellectual property developed through the BTG-funded research programme. |
|
|
| TolerRx, Inc. Advance TRX4 in Type 1 Diabetes - Adds seven new investors including FrontPoint Partners |
26 September 2006 - BTG
TolerRx, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat patients with diseases of the immune system, announced that it has completed a $35.6 million financing, which included funding from the Juvenile Diabetes Research Foundation, the world's largest charitable sponsor of research in Type 1 diabetes. The funds will support the clinical development of TolerRx's lead product, TRX4, an anti-CD3 monoclonal antibody in development for Type 1 diabetes and psoriasis. TolerRx is currently conducting clinical trials of TRX4 in subjects with Type 1 diabetes and plans to initiate a Phase III pivotal trial. |
|
|
| BTG plc: Varisolve given FDA approval to recommence US clinical trials |
26 September 2006 - BTG
BTG plc, the medical innovations company, today announces that its subsidiary Provensis has received approval from the US Food and Drug Administration to resume clinical development of Varisolve, which is being developed as a novel microfoam treatment for varicose veins. |
|
|
| Map sheds light on ocean floor |
26 September 2006 - CSIRO
The result of a major research initiative between the CSIRO’s Wealth from Oceans Flagship, and Geoscience Australia, together with CSIRO Exploration and Mining and the State and Territory Geological Surveys, the map was launched today by the Minister for Industry, Tourism and Resources, Ian Macfarlane, and the Minister for Education, Science and Training, Julie Bishop. |
|
|
| Researchers are investigating Koi herpesvirus as a means of controlling the introduced fish |
26 September 2006 - CSIRO
Project leader Dr Mark Crane says the virus, which first emerged in Israel in 1998, caused mass mortalities in carp in the US, the UK, Israel, the Netherlands, Japan and Indonesia. So far the virus does not appear to have reached Australia. |
|
|
| Researchers are investigating Koi herpesvirus as a means of controlling the introduced fish |
26 September 2006 - CSIRO
Project leader Dr Mark Crane says the virus, which first emerged in Israel in 1998, caused mass mortalities in carp in the US, the UK, Israel, the Netherlands, Japan and Indonesia. So far the virus does not appear to have reached Australia. |
|
|
| Map sheds light on ocean floor |
26 September 2006 - CSIRO
The world’s first map to show a comprehensive summary of known offshore mineral occurrences has been released for Australia’s vast marine jurisdiction.
The map shows the known seafloor locations of minerals, such as copper, gold, silver and diamond, compiled from survey information gathered over many decades. |
|
|
| Completed genome set to transform the cow |
25 September 2006 - CSIRO
The ability of scientists to improve health and disease management of cattle and enhance the nutritional value of beef and dairy products has received a major boost with the release this week of the most complete sequence of the cow genome ever assembled. |
|
|
| Brookhaven lab researchers develop a method for producing electrodes using nanoscale materials |
25 September 2006 - DOE/Brookhaven National Laboratory
Using nanoscale materials, researchers from the U.S. Department of Energy’s Brookhaven National Laboratory have developed a method to make electrodes that are suitable for use in rechargeable lithium ion batteries and other electronic devices. |
|
|
| A new international research project that seeks to protect the environment from metal contaminants will be launched |
25 September 2006 - CSIRO
The project will be launched at the Society of Environmental Toxicology and Chemistry Asia/Pacific Conference. It will bring together scientists from CSIRO, the Chinese Academy of Sciences and the Chinese Academy of Agricultural Sciences, and is sponsored by Rio Tinto, the International Copper Association and the Nickel Producers Environmental Research Association. |
|
|
| Completed genome set to transform the cow |
25 September 2006 - CSIRO
The ability of scientists to improve health and disease management of cattle and enhance the nutritional value of beef and dairy products has received a major boost with the release this week of the most complete sequence of the cow genome ever assembled. |
|
|
| A new international research project seeks to protect environment from metal contaminants will be launched |
25 September 2006 - CSIRO
The project will be launched at the Society of Environmental Toxicology and Chemistry Asia/Pacific Conference. It will bring together scientists from CSIRO, the Chinese Academy of Sciences and the Chinese Academy of Agricultural Sciences, and is sponsored by Rio Tinto, the International Copper Association and the Nickel Producers Environmental Research Association. |
|
|
| BTG establishes collaboration agreement with Collegium Pharmaceutical to develop innovative therapy for sleep apnoea |
25 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced today that it has entered into a Collaboration Agreement with Collegium Pharmaceutical, Inc., to develop novel formulations of its combination drug therapy currently being developed for the treatment of sleep apnoea. Collegium will employ its expertise in product development, including its suite of proprietary formulation technologies, with the goal of establishing a broadly patented single product with optimal properties for the treatment of this sleep-related breathing disorder. The Collaboration Agreement provides for a development programme that will be funded by BTG, as well as a revenue sharing arrangement between the parties. The intent of this Collaboration Agreement is for the sleep apnoea project to be the first of additional co-development programmes between the companies. |
|
|
| BTG licenses fundamental online navigation tracking patents to Netflix |
25 September 2006 - BTG
BTG plc announced it has reached a full and final settlement with Netflix Inc. in connection with a patent infringement lawsuit filed by BTG in September 2004 against Netflix and other organisations. As a result of this settlement, BTG has dismissed its claims against Netflix and granted Netflix a non-exclusive licence to patents covering technology for tracking the navigational path of a user through the World Wide Web. The suit against the other parties, Amazon.com, BarnesandNoble.com and Overstock.com, continues to be pursued. The financial terms of the settlement with Netflix are undisclosed. |
|
|
| BTG announces availability of a Novel Chalcogenide Laser for License |
25 September 2006 - BTG
BTG, the IP and technology commercialisation company, today announced that it is offering for license patented, fundamental chalcogenide semiconductor laser technology, which can provide broad functionality for sensing and laser ablation applications. The technology package, originally developed at the Lawrence Livermore National Laboratory, provides a versatile, tuneable, and more economical alternative to products already available on the market. A commercial prototype is currently under development at Canada’s INO and will be available to demonstrate this technology. |
|
|
| BTG announces availability of a Novel Chalcogenide Laser for License |
25 September 2006 - BTG
BTG, the IP and technology commercialisation company, today announced that it is offering for license patented, fundamental chalcogenide semiconductor laser technology, which can provide broad functionality for sensing and laser ablation applications. |
|
|
| BTG establishes collaboration agreement with Collegium Pharmaceutical |
25 September 2006 - BTG
BTG, the intellectual property and technology commercialisation company, announced today that it has entered into a Collaboration Agreement with Collegium Pharmaceutical, Inc., to develop novel formulations of its combination drug therapy currently being developed for the treatment of sleep apnoea. |
|
|
| BTG licensee TolerRx, Inc. raises $35.6m to develop TRX4; Phase III pivotal trial in type 1 diabetes |
25 September 2006 - BTG
BTG plc, the medical innovations company, today announces that TolerRx, Inc. has raised $35.6 million to advance the development of TRX4 as a treatment for type 1 diabetes and plans to commence a Phase III pivotal trial in 2006. TolerRx, BTG's exclusive licensee for the anti-CD3 monoclonal antibody TRX4, is also developing TRX4 as a treatment for psoriasis. |
|
|
| BTG licenses fundamental online navigation tracking patents to Netflix |
25 September 2006 - BTG
BTG plc announced it has reached a full and final settlement with Netflix Inc. in connection with a patent infringement lawsuit filed by BTG in September 2004 against Netflix and other organisations. As a result of this settlement, BTG has dismissed its claims against Netflix and granted Netflix a non-exclusive licence to patents covering technology for tracking the navigational path of a user through the World Wide Web. |
|
|
| Application of sourcing skills to aspects of its human resources buy is yielding 8-10% |
25 September 2006 - Boothroyd Dewhurst
Application of sourcing skills to aspects of its human resources buy is yielding 8-10% annual savings for Intel Corp., which is a world leader in managing indirect spend. Development of a global medical insurance program saved 23% through an online bidding event. A five-lot Internet negotiations strategy for a life and health insurance program in China yielded savings of 38%. |
|
|
| New design for manufacturing and assembly application on the design of ASH64D Helicopter |
25 September 2006 - Boothroyd Dewhurst
This new study examines the effectiveness of Design for Manufacturing and Assembly methodology used by the design, manufacturing, quality, and supporting engineers for the development of the Longbow Apache Helicopter. Data were obtained through the Integrated Product Development team for several redesigned areas of the Longbow prototype Helicopter Crew Station. Results of the study show that DFMA can be an effective approach, as indicated by a significant cost and weight savings. |
|
|
| New DFMA software from Boothroyd Dewhurst offers the most comprehensive tools available |
25 September 2006 - Boothroyd Dewhurst
Boothroyd Dewhurst, Inc. announced a new version of the company’s internationally recognized Design for Manufacture and Assembly software. The software contains new versions of both modules in the integrated DFMA suite: DFA Version 9.3, and DFM Concurrent Costing Version 2.2. |
|
|
| BOC and Cellex Power to supply hydrogen and fuel cell products for forklift trucks |
25 September 2006 - BOC Gases
Forklift trucks will soon be the latest vehicles powered by clean and efficient hydrogen energy, thanks to an agreement between BOC, one of the world’s largest industrial gases companies, and Cellex Power Products Inc., the leader in fuel cell power solutions for industrial vehicles. |
|
|
| BOC offers bakers a perfect recipe, time after time |
24 September 2006 - BOC Gases
Murray Hill, New Jersey, U.S., July 21, 2004, BOC (NYSE:BOX) will show bakers how they can achieve a perfect recipe, time after time, with the company’s range of technology-based, value-added solutions on display at the International Baking Industry Exposition in Las Vegas, Nevada. |
|
|
| 1500-Pump monitoring system is BOC Edwards’ largest networked facility in the world |
24 September 2006 - BOC Gases
Managing an entire system of over 1500 vacuum pumps as well as multiple exhaust management systems in a manufacturing environment where downtime can rise above tens of thousands of dollars per hour is a challenge that has been successfully met by monitoring and reporting specialists at BOC Edwards. |
|
|
| BOC's dolphin-shaped car makes a splash |
24 September 2006 - BOC Gases
The BOC Gh2ost, being tested on the remote island of Shetland, off the north coast of Scotland, is expected to be able to travel around the world on less than the equivalent of two gallons of petrol; using 25 watts, a fraction of the power a light bulb uses. |
|
|
| Intervent offers anti-microbial technologies for food and beverage |
24 September 2006 - BOC Gases
Intervent, the new food safety technology and consulting arm of BOC, is providing food and beverage manufacturers with a single source for addressing their plants food safety needs. |
|
|
| BOC joint venture to supply oxygen to new mono ethylene glycol plant in Map Ta Phut, Thailand |
24 September 2006 - BOC Gases
MIG Production Co. Ltd, a joint venture between Thai Industrial Gases PCL and Bangkok Industrial Gas Company Ltd has been awarded a long-term contract to supply 800 tonnes a day of oxygen to a new mono ethylene glycol project operated by TOC Glycol Co. Ltd. in Map Ta Phut, Thailand. |
|
|
| BOC opens largest commercial helium facility in China |
24 September 2006 - BOC Gases
BOC, one of the world's leading helium suppliers, has recently opened the largest commercial helium facility in China, a distribution center located in Suzhou. |
|
|
| BOC resuscitators essential for dental |
24 September 2006 - BOC Gases
With the ability to deliver oxygen up to six times better than the mouth to mouth technique, LifeLine and LifeLine-PRO, the resuscitator kits from oxygen specialist BOC Medical are essential lifesaving tools for the dental practitioner. |
|
|
| BOC powered hydrogen bus supports Guildford's Ambient Picnic |
23 September 2006 - BOC Gases
The UK's first ever zero emission bus will give Surrey residents an alternative view of public transport at the Ambient Picnic 2005, Guildford's annual music art and environment festival. |
|
|
| South Korea facility is the world’s first Generation 7 TFT LCD fab |
23 September 2006 - BOC Gases
BOC Edwards, an integrated supplier of gas, chemical, vacuum and exhaust management solutions to the flat panel and semiconductor industries, has received a major vacuum systems order from Samsung Electronics. Over 60 vacuum systems will be supplied for Samsung’s Generation 7 thin film transistor-liquid crystal display manufacturing facility in Taenjong, South Korea. |
|
|
| BOC Edwards announces construction of China Silane Transfill Facility |
23 September 2006 - BOC Gases
BOC Edwards, a global supplier of materials, equipment and services to the microelectronics manufacturing industry, announced today it will construct a 60-tonnes per year high-purity silane transfill facility in Kunshan, Suzhou, China. Local distribution facilities, known as transfills, compress bulk gas into cylinders for shipment to customer sites. |
|
|
| HKO to build new air separation plant to support GIS expansion |
23 September 2006 - BOC Gases
Hong Kong Oxygen, a joint venture between BOC and Air Liquide, will construct a new air separation unit to supply Guangzhou Iron & Steel’s steel making operations in the Pearl River region of southern China. |
|
|
| BOC Balloon Gas on the up and now on-line |
23 September 2006 - BOC Gases
Balloons are not just kids’ play. They are serious business, and whatever your business a new website from BOC’s Balloon Gas team has the answer to all your balloon needs. |
|
|
| BOC Edwards Sets new standard with iGX Drypump Platform |
23 September 2006 - BOC Gases
BOC Edwards, a leader in the supply of vacuum systems and services, has announced the launch of its new iGX platform, responding to an industry need for a versatile, low utility cost, high-reliability, high-performance drypump for semiconductor processes. |
|
|
| Research project set to uncover the future of helium |
23 September 2006 - BOC Gases
The UK's biggest provider of helium is joining forces with a major user and Cambridge academics to sponsor a three year research project, the results of which are expected to reveal how much longer industry can rely on this increasingly scare resource. |
|
|
| BOC Edwards begins second phase of pipeline network in Taiwan's Hsinchu Science Park |
22 September 2006 - BOC Gases
BOC Edwards, in conjunction with its Taiwan joint venture partner, BOC Lien Hwa, has begun work on the next phase of expansion of its nitrogen production and pipeline distribution network, at a cost of more than US $30 million, in the Hsinchu Science Park in northern Taiwan. |
|
|
| BOC cryogenic impingement freezer boosts production, reduces cost for King & Prince Seafood |
22 September 2006 - BOC Gases
King & Prince Seafood Company has replaced two freezers with a single, BOC cryogenic impingement freezer at its Brunswick, Georgia processing plant, enabling it to increase production while lowering costs and reducing yield loss. |
|
|
| BOC Medical to deliver key messages to the UK medical sector |
22 September 2006 - BOC Gases
BOC Medical will use three major medical conferences to promote its range of services and reinforce its position as a health care partner to the UK health sector.
The benefits of heliox in treating patients with airway obstructions, such as acute asthma and chronic obstructive pulmonary disease, will be the key message at the Intensive Care Society’s spring conference in Torquay. |
|
|
| Indura oxygen plant enables start-up of environmentally sustainable copper production in Chile |
22 September 2006 - BOC Gases
Indura, one of Latin America’s leading suppliers of industrial gases, has constructed Chile’s first on-site oxygen plant dedicated to clean, environmentally sustainable copper production. The high-purity oxygen is a vital part of Alliance Copper Ltd.’s landmark copper bioleaching prototype production facility in Calama, Chile. |
|
|
| CuNoSS liquid abatement technology eliminates hazardous copper ions without requiring solids pre-filtration |
22 September 2006 - BOC Gases
BOC Edwards, a major supplier of materials, equipment and services to the semiconductor industry, has successfully completed a wastewater treatment evaluation program with STMicroelectronics, one of the world’s leading semiconductor manufacturers. |
|
|
| BOC expands its ISO 17025 accredited network |
22 September 2006 - BOC Gases
BOC has received accreditation for the international standard ISO/IEC 17025 for EPA Protocol gases and NIST traceable gas mixtures at its Riverton, New Jersey facility. This is the second such accredited BOC facility in the U.S., accreditation of the company’s Royal Oak, Michigan facility was announced in May 2003. At least one additional BOC production facility is scheduled for ISO 17025 accreditation. |
|
|
| BOC Sureflow's new filling operation receives the Theakston seal of approval |
22 September 2006 - BOC Gases
BOC Sureflow’s new dispense gas cylinder filling operation in Salford has been officially opened by one of the most famous names in the UK brewing industry.
Edward Theakston, a member of the Theakston family* whose original brewery was founded in 1827, unveiled a plaque to commemorate the opening of the state-of-the-art Suremix filling operation which will produce carbon dioxide and nitrogen mixtures for beer, lager and stout dispense. |
|
|
| New Generation-F designed to lower chamber cleaning cost of ownership |
22 September 2006 - BOC Gases
BOC Edwards, a leading supplier of materials, equipment and services to the flat panel display manufacturing industry, announced today the launch of the Generation-F 1600, a new addition to its family of on-site fluorine generators. The Generation-F 1600 will be introduced at FPD TAIWAN 2005. |
|
|
| The green car will deliver on performance and looks as well as emission reduction |
21 September 2006 - BOC Gases
A wholly British partnership today unveiled plans to develop the world’s first environmentally clean sports car, powered by a fuel cell which converts hydrogen into electricity. |
|
|
| BOC introduces on-site chlorine purification for optical fiber manufacture |
21 September 2006 - BOC Gases
BOC has developed a patent-pending on-site chlorine purification technology that reduces optical fiber manufacturing costs by converting cheaper industrial grade chlorine into high-purity, lower moisture chlorine gas suitable for making optical fibers. |
|
|
| BOC expands leadership position in China |
21 September 2006 - BOC Gases
BOC, the number one industrial gases company in Asia, has further expanded its leadership position in China by signing a major contract for the supply of oxygen to the Taiyuan Iron and Steel Corporation, located in the Shanxi province of north-central China. |
|
|
| BOC technology validated for controlling Listeria on ready-to-eat meat and poultry products |
21 September 2006 - BOC Gases
BOC technology aimed at making food safer for consumers by controlling Listeria (L. monocytogenes) has been validated by Kansas State University and accepted by the U.S. Department of Agriculture’s Food Safety Inspection Service. |
|
|
| BOC Sureflow promotes cellar space solution at Pub & Bar show |
21 September 2006 - BOC Gases
The licensed trade can now offer customers a wider range of beers without a cellar full of different mixed gases cylinders thanks to BOC Sureflow’s SureBlend range.
The public’s demand for an increasing number of beers had meant the need to stock several different mixtures, which means more cylinders in the cellar and more frequent cylinder changes. |
|
|
| BOC urges car drivers to be ready for summer |
21 September 2006 - BOC Gases
For many car drivers, the need to ensure the air conditioning system is ready for the summer comes well down the list of maintenance checks behind the oil, filters, tyres and brakes, but now is the right time to test for leaks, says BOC. |
|
|
| BOC and MORE expand energy injection system product offering to steel recycling industry |
21 September 2006 - BOC Gases
BOC, a major supplier to the global steel industry, and MORE S.r.l., a worldwide leader in supplying chemical energy and injection systems to electric arc furnace steelmaking, announce the next step in their five-year partnership, the MORE Hi_JET. |
|
|
| Superconducting system provides three to five times more power capacity |
20 September 2006 - BOC Gases
This summer, when the demand for electricity to run pool pumps, fans and air conditioners is at its peak, power customers in Albany, N.Y., will get some extra capacity thanks to new technology. A system that eliminates the resistance that causes power losses in traditional copper cables has begun operating, providing enough power for more than 70,000 area households. |
|
|
| New foam blowing agent will help sector meet emissions targets |
20 September 2006 - BOC Gases
Industrial and special gases company BOC is set to help cut the rate of ozone depleting emissions across the building sector with the introduction of EcomateR an environmentally friendly foam blowing agent. |
|
|
| BOC helps Macy’s pump-up Thanksgiving |
20 September 2006 - BOC Gases
BOC, the world's largest helium supplier, and Macy's are again teaming up to celebrate Thanksgiving and to make children of all ages smile at the Macy's Thanksgiving Day Parade(R). |
|
|
| Cylinder safety boosted by autumn colour change |
20 September 2006 - BOC Gases
BOC the industrial and special gases company is changing the identification colours of its gas cylinders as part of a European move to make gases and their associated hazards easy to identify. |
|
|
| BOC hardy annual holds answer to every welding query |
20 September 2006 - BOC Gases
BOC Industrial is issuing its popular welding and cutting manual, BOC Tradefile, in a new hardbound catalogue and for the first time in the UK is to make it available to retail teams and over the counter at selected BOC Industrial trade outlets. |
|
|
| BOC Foundation supports hydrogen fuel cell urban concept car |
20 September 2006 - BOC Gases
The BOC Foundation has awarded OSCar Automotive a grant to develop a powertrain for a two-seat urban vehicle powered by a hydrogen fuel cell. The grant will help fund the two year Hyrban project which aims to prove that practical hydrogen fuel cell urban vehicles are readily engineered using existing fuel cell technology. |
|
|
| Helping industry ensure a safe working environment |
20 September 2006 - BOC Gases
The bocsafety.net site provides solutions to health and safety related challenges across a range of UK sectors including the automotive and marine industries, heavy industry, light engineering, general welding and metal cutting, and research and development. Says Martin Passingham, BOC Industrial market manager, “The bocsafety.net site aims to be a trusted source of advice and information, helping industrial operators work to legal compliance and to ensure a safer working environment”. |
|
|
| LG.Philips LCD Selects BOC Edwards Vacuum Pump Systems for New LCD Plant 7 |
19 September 2006 - BOC Gases
Global materials, equipment, and services provider, BOC Edwards, announced today it has been selected to supply a majority of the vacuum pump systems for LG.Philips LCD Plant 7, currently under construction in Paju, Korea. LG.Philips LCD, Seoul, is a leading manufacturer of TFT-LCD (thin film transistor-liquid crystal display) panels. The order includes iHxK and diFxK vacuum systems specifically designed by BOC Edwards to support LCD process applications. |
|
|
| BOC and Dabbrook combine alternative technologies to help Environment Agency in East Anglia |
19 September 2006 - BOC Gases
An automated system, powered by solar energy and hydrogen fuel cells is bringing a much needed solution to the Environment Agency's water management on the river Deben in Suffolk. |
|
|
| Shock technology boosts British food hygiene |
19 September 2006 - BOC Gases
Sonic shockwaves that boost food hygiene by dramatically reducing cooking and cleaning time are at the core of a revolutionary process, PDX Sonic25, winner of the BOC sponsored technological development of the year at the Food Processing magazine awards held at the Copthorne Effingham Park Hotel, Gatwick. |
|
|
| BOC’s Think Gates helps food processors improve process monitoring capabilities |
19 September 2006 - BOC Gases
Food processors looking for ways to address plant production issues like fluctuating yield, poor efficiency and product inconsistency can get help from Think Gates(R), a BOC process optimization and service technology business. |
|
|
| Toledo family gets new home through BOC and Habitat for Humanity |
19 September 2006 - BOC Gases
Toledo, Ohio, mother who hoped for a safer neighborhood for her two children is going to get her wish, thanks to Habitat for Humanity and BOC. Crystal Casida will move with her son, Nicholas, 8 and daughter, Jayceona, 5, to a house in Holland, Ohio. BOC, one of the world’s largest industrial gases suppliers, sponsored the house through the Maumee Valley Habitat for Humanity. Construction begins this month; the house should be finished in 2006. |
|
|
| BOC carbon fibre cylinder makes oxygen lighter and safer to use |
19 September 2006 - BOC Gases
The latest addition to a new generation of medical gas cylinders is helping hospitals and emergency services deliver life-saving oxygen more efficiently, easily and safely. |
|
|
| BOC Edwards announces new liquid abatement system for metal electroplating waste |
19 September 2006 - BOC Gases
BOC Edwards, a leading supplier of vacuum and abatement equipment to the world’s 300 mm semiconductor fabs, announced today the release of its new electroplated metals abatement system product, which offers simplified liquid waste treatment and lower cost of ownership than conventional approaches. |
|
|
| Indium Corporation assists special Olympians |
19 September 2006 - Indium Corporation
Indium Corporation participated in the Special Olympics Airlift, which provides transportation to over 1,500 athletes from all over the country to the 2006 US National Games in Ames, Iowa, USA. In a well-coordinated effort synchronized by the Cessna Corporation, 235 volunteer Cessna Citations transported the athletes to Iowa for the start of the games, then back home again after the closing ceremonies. |
|
|
| BOC to build only carbon dioxide plant in U.S. Northeast |
18 September 2006 - BOC Gases
BOC, one of the world's largest industrial gases companies, is expanding its carbon dioxide capacity with a new plant in Volney, New York. The plant will be the first CO2 plant built in the Northeast in nearly two decades and will be the only CO2 plant in the region. |
|
|
| SOXAL extends collaboration with chartered for nitrogen gas supply To 300mm Fab |
18 September 2006 - BOC Gases
Singapore Oxygen Air Liquide Pte Ltd, a joint venture between The BOC Group and Air Liquide, has signed a bulk gas contract with Chartered Semiconductor Manufacturing, one of the world's top semiconductor foundries, for the supply of nitrogen to Chartered's 300 mm facility, Fab 7. |
|
|
| New dry semiconductor wafer cleaning process |
18 September 2006 - BOC Gases
Eco-Snow Systems, a member of The BOC Group, and the leading supplier of dry carbon dioxide snow-based wafer cleaning tools, has introduced a new process for semiconductor wafer cleaning that eliminates the negative side effects of traditional plasma cleaning. |
|
|
| New British hydrogen vehicle will attempt the world efficiency record using a driver aged just 13 |
18 September 2006 - BOC Gases
BOC's dolphin-shaped eco-marathon vehicle, the BOC Ech2o is ready to attempt the world fuel efficiency record. The BOC Ech2o has been designed with a simple goal to demonstrate fuel efficiency. |
|
|
| BOC’s extended range of patio equipment set to boost pub sales from outdoor dining |
18 September 2006 - BOC Gases
Exploiting the trend for outdoor dining on cooler evenings could increase pub and restaurant sales by as much as 25 per cen |
